# OXYMETAZOLINE
> **ANDA211812** · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA INC · Approved 2022-10-28
## Drug
- **FDA Application Number:** ANDA211812
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** OXYMETAZOLINE
- **Generic name:** Oxymetazoline
- **Active ingredients:** OXYMETAZOLINE
- **Dosage form:** CREAM
- **Route:** TOPICAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** TEVA PHARMS USA INC
- **First approval:** 2022-10-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211812)
---
*MORVS · CC0 1.0*